Literature DB >> 1359907

An active-site mutation (Gly633-->Arg) of dipeptidyl peptidase IV causes its retention and rapid degradation in the endoplasmic reticulum.

E Tsuji1, Y Misumi, T Fujiwara, N Takami, S Ogata, Y Ikehara.   

Abstract

Dipeptidyl peptidase IV (DPPIV), a serine protease expressed on the cell surface, is deficient in a Fischer rat substrain. Northern blot analysis showed no difference in the size and amount of DPPIV mRNA between normal (344/NC) and deficient (344/CRJ) rats. Cloning and sequencing of DPPIV cDNAs revealed a G to A transition at nucleotide 1897 in the cDNA sequence of 344/CRJ, which leads to substitution of Gly633-->Arg in the active-site sequence Gly629-Trp-Ser-Tyr-Gly633 determined for the wild-type DPPIV [Ogata, S., Misumi, Y., Takami, N., Oda, K., & Ikehara, Y. (1992) Biochemistry 31, 2582-2587]. Pulse-chase experiments with hepatocytes showed that the wild-type DPPIV was initially synthesized as a 103-kDa form with high-mannose-type oligosaccharides, which was processed to a mature form of 109 kDa with the complex type during intracellular transport. In contrast, the mutant DPPIV, although being synthesized as the 103-kDa form, was rapidly degraded without being processed to the mature form. Site-directed mutagenesis of the wild-type and mutant cDNAs and their transfection/expression in COS-1 cells confirmed that the single substitution of Gly633-->Arg is sufficient to cause the rapid intracellular degradation of DPPIV. Immunoelectron-microscopic observations showed that the mutant DPPIV was detectable only in the endoplasmic reticulum (ER), in contrast to the distribution of the wild-type DPPIV in the Golgi complex and on the cell surface.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1359907     DOI: 10.1021/bi00162a035

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Dipeptidyl peptidase-4 deficiency protects against experimental diabetic nephropathy partly by blocking the advanced glycation end products-receptor axis.

Authors:  Takanori Matsui; Sae Nakashima; Yuri Nishino; Ayako Ojima; Nobutaka Nakamura; Kazunari Arima; Kei Fukami; Seiya Okuda; Sho-ichi Yamagishi
Journal:  Lab Invest       Date:  2015-03-02       Impact factor: 5.662

Review 2.  What doesn't kill you makes you stranger: Dipeptidyl peptidase-4 (CD26) proteolysis differentially modulates the activity of many peptide hormones and cytokines generating novel cryptic bioactive ligands.

Authors:  Ahmed M Elmansi; Mohamed E Awad; Nada H Eisa; Dmitry Kondrikov; Khaled A Hussein; Alexandra Aguilar-Pérez; Samuel Herberg; Sudharsan Periyasamy-Thandavan; Sadanand Fulzele; Mark W Hamrick; Meghan E McGee-Lawrence; Carlos M Isales; Brian F Volkman; William D Hill
Journal:  Pharmacol Ther       Date:  2019-02-10       Impact factor: 12.310

3.  Is the Fischer 344/CRJ rat a protein-knock-out model for dipeptidyl peptidase IV-mediated lung metastasis of breast cancer?

Authors:  H C Cheng; M Abdel-Ghany; S Zhang; B U Pauli
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

4.  CD26 (dipeptidyl-peptidase IV)-dependent recruitment of T cells in a rat asthma model.

Authors:  C Kruschinski; T Skripuletz; S Bedoui; T Tschernig; R Pabst; C Nassenstein; A Braun; S von Hörsten
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

5.  Role of 26S proteasome and HRD genes in the degradation of 3-hydroxy-3-methylglutaryl-CoA reductase, an integral endoplasmic reticulum membrane protein.

Authors:  R Y Hampton; R G Gardner; J Rine
Journal:  Mol Biol Cell       Date:  1996-12       Impact factor: 4.138

6.  Regulation of expression and function of dipeptidyl peptidase 4 (DP4), DP8/9, and DP10 in allergic responses of the lung in rats.

Authors:  Jutta Schade; Michael Stephan; Andreas Schmiedl; Leona Wagner; André J Niestroj; Hans-Ulrich Demuth; Nadine Frerker; Christian Klemann; Kerstin A Raber; Reinhard Pabst; Stephan von Hörsten
Journal:  J Histochem Cytochem       Date:  2007-10-29       Impact factor: 2.479

7.  Airway-specific recruitment of T cells is reduced in a CD26-deficient F344 rat substrain.

Authors:  J Schade; A Schmiedl; A Kehlen; T Z Veres; M Stephan; R Pabst; S von Hörsten
Journal:  Clin Exp Immunol       Date:  2009-10       Impact factor: 4.330

8.  Molecular and cellular basis of deficiency of the b subunit for factor XIII secondary to a Cys430-Phe mutation in the seventh Sushi domain.

Authors:  T Hashiguchi; A Ichinose
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

9.  The binding site of human adenosine deaminase for CD26/Dipeptidyl peptidase IV: the Arg142Gln mutation impairs binding to cd26 but does not cause immune deficiency.

Authors:  E Richard; F X Arredondo-Vega; I Santisteban; S J Kelly; D D Patel; M S Hershfield
Journal:  J Exp Med       Date:  2000-11-06       Impact factor: 14.307

10.  Regulated degradation of HMG-CoA reductase, an integral membrane protein of the endoplasmic reticulum, in yeast.

Authors:  R Y Hampton; J Rine
Journal:  J Cell Biol       Date:  1994-04       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.